Article | November 17, 2022

What Happens When Your CRO Is Acquired? A Vendor Oversight Approach And Response

Source: Harbor Clinical
CRO Selection Taken Seriously

M&A deals can be extremely beneficial for small CROs. Being purchased by a larger entity reduces financial uncertainty while presenting opportunities to scale. Likewise, these acquisitions expose small CROs to additional markets and clients. However, M&A deals can also cause disruption, as teams converge and processes intersect, and these growing pains are often felt by sponsors. 

In this paper, we look at the growing M&A trend, highlight some of the challenges that M&A deals present, and discuss how investing in vendor oversight services can ensure quality, timeliness, and peace of mind.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader